MAZE Latest Headlines

Wall Street Analysts Are Bullish on Top Healthcare Picks

at www.tipranks.com (Tue, 7-Apr 7:20 AM)

Maze Therapeutics' Positive Phase 2 Data and $360M Cash Runway Highlight Strong Foundation for Kidney and Metabolic Disease Pipeline

Market Chameleon (Thu, 26-Mar 11:45 AM)

Maze Therapeutics Advances Kidney Disease Pipeline with Strong Phase 2 Data and Expands Leadership

Market Chameleon (Wed, 25-Mar 7:54 AM)